Bahian, Emelia S.
HRN: 22-23-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/22/2022
12/28/2022
IV INFUSION TO RUN FOR 6 HOURS
1.5 G
Q6H
Community Acquired Pneumonia- High Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes